XSPRAYXspray Pharma AB (publ)
10.46SEK+0.58%Mkt Cap: 47.44M $P/E:

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the…